Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00164073
What this trial is testing

Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Bayside Health 60
Testing effectiveness (Phase 2)Study completedNCT00196586
What this trial is testing

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Who this might be right for
HIV InfectionsChronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 75
Post-approval studies (Phase 4)Ended earlyNCT00977054
What this trial is testing

Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load

Who this might be right for
Hepatitis C
National Taiwan University Hospital 59
Not applicableStudy completedNCT01671046
What this trial is testing

An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 123
Post-approval studies (Phase 4)Study completedNCT00163657
What this trial is testing

Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

Who this might be right for
End Stage Liver DiseaseHepatitis C
Baylor Research Institute 312
Post-approval studies (Phase 4)Ended earlyNCT00279565
What this trial is testing

Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Indivior Inc. 128
Large-scale testing (Phase 3)Study completedNCT03069365
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 101
Post-approval studies (Phase 4)UnknownNCT00127777
What this trial is testing

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Who this might be right for
Hepatitis C, Chronic
University Hospital, Saarland 700
Not applicableStudy completedNCT00727311
What this trial is testing

Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 2,302
Not applicableUnknownNCT05474781
What this trial is testing

Eliminating HCV Infection Among PWUD

Who this might be right for
Hepatitis C, ChronicDrug Use
Vancouver Infectious Diseases Centre 300
Not applicableStudy completedNCT03145623
What this trial is testing

Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease

Who this might be right for
Hepatitis CChronic Kidney Diseases
University Hospital, Toulouse 100
Not applicableStudy completedNCT02907996
What this trial is testing

Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea

Who this might be right for
Hepatitis C Virus
Gilead Sciences 2,033
Not applicableStudy completedNCT04943588
What this trial is testing

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

Who this might be right for
Hepatitis C, Chronic
Queen Mary University of London 25,000
Post-approval studies (Phase 4)Study completedNCT00351403
What this trial is testing

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
FGK Clinical Research GmbH 390
Not applicableStudy completedNCT02648022
What this trial is testing

Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment

Who this might be right for
Hepatitis CDepressionPTSD+2 more
VA Office of Research and Development 83
Testing effectiveness (Phase 2)Study completedNCT01445795
What this trial is testing

Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 50
Post-approval studies (Phase 4)Study completedNCT01120795
What this trial is testing

Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy

Who this might be right for
Chronic Hepatitis C
Melbourne Health 55
Not applicableStudy completedNCT00723645
What this trial is testing

Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 279
Testing effectiveness (Phase 2)Study completedNCT01188772
What this trial is testing

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

Who this might be right for
Hepatitis C Virus
Gilead Sciences 147
Large-scale testing (Phase 3)Ended earlyNCT01095445
What this trial is testing

EXtended Therapy in Hepatitis C Genotype 3 Infected Patients

Who this might be right for
Chronic Hepatitis C
University Health Network, Toronto 2
Next Page